Park Electrochemical Earnings Calls
| Release date | Oct 09, 2025 |
| EPS estimate | - |
| EPS actual | $0.120 |
| Revenue estimate | - |
| Revenue actual | 16.381M |
| Release date | Jul 15, 2025 |
| EPS estimate | - |
| EPS actual | $0.100 |
| Revenue estimate | - |
| Revenue actual | 15.4M |
| Release date | May 15, 2025 |
| EPS estimate | - |
| EPS actual | $0.120 |
| Revenue estimate | - |
| Revenue actual | 16.939M |
| Release date | Jan 14, 2025 |
| EPS estimate | - |
| EPS actual | $0.0800 |
| Revenue estimate | - |
| Revenue actual | 14.408M |
Last 4 Quarters for Park Electrochemical
Below you can see how PKE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jan 14, 2025 |
| Price on release | $14.23 |
| EPS estimate | - |
| EPS actual | $0.0800 |
| Date | Price |
|---|---|
| Jan 07, 2025 | $14.24 |
| Jan 08, 2025 | $14.04 |
| Jan 10, 2025 | $13.78 |
| Jan 13, 2025 | $13.98 |
| Jan 14, 2025 | $14.23 |
| Jan 15, 2025 | $14.45 |
| Jan 16, 2025 | $14.02 |
| Jan 17, 2025 | $14.67 |
| Jan 21, 2025 | $14.99 |
| 4 days before | -0.0702% |
| 4 days after | 5.34% |
| On release day | 1.55% |
| Change in period | 5.27% |
| Release date | May 15, 2025 |
| Price on release | $13.84 |
| EPS estimate | - |
| EPS actual | $0.120 |
| Date | Price |
|---|---|
| May 09, 2025 | $13.27 |
| May 12, 2025 | $13.50 |
| May 13, 2025 | $13.60 |
| May 14, 2025 | $13.47 |
| May 15, 2025 | $13.84 |
| May 16, 2025 | $14.01 |
| May 19, 2025 | $13.99 |
| May 20, 2025 | $13.93 |
| May 21, 2025 | $13.72 |
| 4 days before | 4.30% |
| 4 days after | -0.87% |
| On release day | 1.23% |
| Change in period | 3.39% |
| Release date | Jul 15, 2025 |
| Price on release | $15.52 |
| EPS estimate | - |
| EPS actual | $0.100 |
| Date | Price |
|---|---|
| Jul 09, 2025 | $15.43 |
| Jul 10, 2025 | $15.33 |
| Jul 11, 2025 | $15.29 |
| Jul 14, 2025 | $15.90 |
| Jul 15, 2025 | $15.52 |
| Jul 16, 2025 | $17.31 |
| Jul 17, 2025 | $17.73 |
| Jul 18, 2025 | $19.61 |
| Jul 21, 2025 | $19.88 |
| 4 days before | 0.583% |
| 4 days after | 28.09% |
| On release day | 11.53% |
| Change in period | 28.84% |
| Release date | Oct 09, 2025 |
| Price on release | $20.81 |
| EPS estimate | - |
| EPS actual | $0.120 |
| Date | Price |
|---|---|
| Oct 03, 2025 | $19.71 |
| Oct 06, 2025 | $19.90 |
| Oct 07, 2025 | $19.95 |
| Oct 08, 2025 | $20.61 |
| Oct 09, 2025 | $20.81 |
| Oct 10, 2025 | $19.71 |
| Oct 13, 2025 | $21.20 |
| Oct 14, 2025 | $21.15 |
| Oct 15, 2025 | $20.94 |
| 4 days before | 5.58% |
| 4 days after | 0.625% |
| On release day | -5.29% |
| Change in period | 6.24% |
Park Electrochemical Earnings Call Transcript Summary of Q3 2025
Q3 overview — Sales of $14.4M slightly exceeded prior guidance but adjusted EBITDA ($2.4M) was well below expectations. Management attributed the EBITDA shortfall to a production/value-of-production (SVP) shortfall, the learning curve and ramp costs associated with new manufacturing lines and new employees, and a pause in high‑margin ablative-material shipments tied to a customer requalification of ArianeGroup's RAYCARB C2B fabric. The company burned down some finished‑goods inventory in Q3 and expects to rebuild inventories and recover production efficiency in Q4. Guidance and cash posture — Q4 sales guidance is $15.5M–$16.3M with EBITDA $3.3M–$3.9M; fiscal‑year sales should be roughly $60–61M. Park ended Q3 with about $70M cash, but management flagged near‑term cash uses (tax installment, potential $5M line purchase with an OEM partner, Solution Treater project). Capital allocation — share repurchases were active in Q3 (~180k shares / $2.36M) but paused thereafter; management remains opportunistic about buybacks while preserving cash for growth opportunities. Market and program drivers — core upside includes a large GE/airframe backlog (A320neo/LEAP engine content), the growing Comac program, the 777X/G E9X opportunity, and newly emphasized military/defense missile and hypersonic programs (several under evaluation with the potential for multi‑$10M annual revenues each). C2B requalification risk & timing — a key OEM requalification is out of Park’s control but is expected (management’s estimate) in March; if completed, pent‑up demand could drive meaningful high‑margin sales (management cited roughly $2.5M to this customer in FY26 as an example). Near-term risks include the C2B shipment approvals (some sales require French government sign‑off), ongoing learning‑curve costs for new lines and hires, and timing of customer production ramps. Management tone — transparent about the miss, accountable for internal production shortcomings, optimistic on long‑term demand (“Juggernaut”) and focused on being prepared even if that causes short‑term P&L drag.
Sign In
Buy PKE